Sign in

CIK 0001630627

  • Accelerated filer

TREACE MEDICAL CONCEPTS, INC.

Sign in to watch
Ticker
TMCI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
FL
Entity type
Operating
EIN
471052611
Phone
+1 904-373-5940
Business address
100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
Open-market buys, last 90 days
$246,654
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$246,654. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Treace John T. +$247K Chief Executive Officer 1 filing

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-24 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −207 634,656
2026-08-09 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −9,814 679,863
2026-03-10 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −1,396 704,677
2026-03-08 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −401 706,073
2026-02-10 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +16,875 $1.05 $18K 706,474
2026-02-10 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) −16,875 0
2026-01-22 Scanlan Sean F. Chief Innovation Officer Grant or award +262,500 689,599
2026-01-21 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +53,500 $0.72 $39K 427,099
2026-01-21 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) +53,500 0
2025-10-24 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −208 373,599
2025-08-09 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −9,814 373,807
2025-07-18 Scanlan Sean F. Chief Innovation Officer Exercise or conversion +33,437 $0.72 $24K 383,621
2025-07-18 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) −33,437 0
2025-03-17 Scanlan Sean F. Chief Innovation Officer Exercise or conversion 10b5-1 +50,000 $1.05 $53K 414,081
2025-03-17 Scanlan Sean F. Chief Innovation Officer Sale 10b5-1 −50,000 $7.97 $398K 364,081
2025-03-17 Scanlan Sean F. Chief Innovation Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −50,000 16,875
2025-03-10 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −1,396 364,081
2025-03-08 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −401 365,477
2025-01-22 Scanlan Sean F. Chief Innovation Officer Grant or award +140,625 365,878
2025-01-10 Scanlan Sean F. Chief Innovation Officer Shares withheld for taxes −4,821 225,253

Page 1 of 3 · 45 trades